Mantle cell lymphoma historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
===Discovery=== | ===Discovery=== | ||
*In 1964, Lennert first described the disease as 'centrocytic' lymphoma. | *In 1964, Lennert first described the disease as 'centrocytic' lymphoma. | ||
*In 1982, Weisenburger first introduced the concept of 'mantle-zone lymphoma'.<ref>{{Cite journal | |||
*In 1992, Banks first coined the term Mantle Cell Lymphoma (MCL). | | author = [[D. D. Weisenburger]], [[H. Kim]] & [[H. Rappaport]] | ||
*In 1994, MCL was included into the Revised European-American Classification of Lymphoid Neoplasms (REAL) classification. | | title = Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma | ||
| journal = [[Cancer]] | |||
| volume = 49 | |||
| issue = 7 | |||
| pages = 1429–1438 | |||
| year = 1982 | |||
| month = April | |||
| pmid = 6895860 | |||
}}</ref> | |||
*In 1992, Banks first coined the term Mantle Cell Lymphoma (MCL).<ref name="pmid1530105">{{cite journal| author=Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K et al.| title=Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. | journal=Am J Surg Pathol | year= 1992 | volume= 16 | issue= 7 | pages= 637-40 | pmid=1530105 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1530105 }} </ref> | |||
*In 1994, MCL was included into the Revised European-American Classification of Lymphoid Neoplasms (REAL) classification, and later also in the World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues. | |||
Revision as of 21:20, 6 November 2018
Mantle cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mantle cell lymphoma historical perspective On the Web |
American Roentgen Ray Society Images of Mantle cell lymphoma historical perspective |
Risk calculators and risk factors for Mantle cell lymphoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ali Akram, M.B.B.S.[2]
Overview
Historical Perspective
Discovery
- In 1964, Lennert first described the disease as 'centrocytic' lymphoma.
- In 1982, Weisenburger first introduced the concept of 'mantle-zone lymphoma'.[1]
- In 1992, Banks first coined the term Mantle Cell Lymphoma (MCL).[2]
- In 1994, MCL was included into the Revised European-American Classification of Lymphoid Neoplasms (REAL) classification, and later also in the World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues.
Landmark Events in the Development of Treatment Strategies
In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].
References
- ↑ D. D. Weisenburger, H. Kim & H. Rappaport (1982). "Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma". Cancer. 49 (7): 1429–1438. PMID 6895860. Unknown parameter
|month=
ignored (help) - ↑ Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K; et al. (1992). "Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data". Am J Surg Pathol. 16 (7): 637–40. PMID 1530105.